{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ROBERT CYRAN", "person": [{"rank": 1, "role": "reported", "firstname": "Robert", "organization": "", "lastname": "CYRAN"}]}, "abstract": null, "type_of_material": "News", "word_count": "369", "lead_paragraph": "An offshore tax address means there\u2019s no reason to keep over $60 billion of cash on its balance sheet. That\u2019s a lot of financial firepower to buy back shares and fuel more acquisitions.", "pub_date": "2015-11-26T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "How Allergan Deal Will Rebuild Pfizer\u2019s War Chest", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "snippet": "An offshore tax address means there\u2019s no reason to keep over $60 billion of cash on its balance sheet. That\u2019s a lot of financial firepower to buy back shares and fuel more acquisitions.", "multimedia": [{"height": 126, "url": "images/2015/11/24/business/24DB-PFIZERjp2/24DB-PFIZERjp2-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/24/business/24DB-PFIZERjp2/24DB-PFIZERjp2-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 395, "url": "images/2015/11/24/business/24DB-PFIZERjp2/24DB-PFIZERjp2-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "395", "xlarge": "images/2015/11/24/business/24DB-PFIZERjp2/24DB-PFIZERjp2-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/24/business/24DB-PFIZERjp2/24DB-PFIZERjp2-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/24/business/24DB-PFIZERjp2/24DB-PFIZERjp2-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/26/business/dealbook/how-allergan-deal-will-rebuild-pfizers-war-chest.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Federal Taxes (US)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Taxation", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Allergan Inc", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Read, Ian C", "name": "persons"}], "blog": [], "_id": "5655fc3c38f0d8310210dbf0", "source": "The New York Times"}